# Lithium Carbonate

NDC: 0054-8527
Generic name: Lithium Carbonate
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, GELATIN COATED
Routes: ORAL
Marketing started: 19801126

FDA application: NDA017812

## Active ingredients

- LITHIUM CARBONATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0054-8527"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0054-8527
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7dc9c6d2-6d9a-49e4-a8ab-437b0ed5f84e